Tension pneumocephalus after administration of two 0.25 mg cabergoline tablets in MEN1-related macroprolactinoma.
作者信息
Nanba Kazutaka, Usui Takeshi, Nakakuki Takuya, Shimatsu Akira
机构信息
Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
出版信息
BMJ Case Rep. 2013 Jun 7;2013:bcr2013009986. doi: 10.1136/bcr-2013-009986.
Abstract
摘要
相似文献
1
Tension pneumocephalus after administration of two 0.25 mg cabergoline tablets in MEN1-related macroprolactinoma.在一名与多发性内分泌腺瘤1型（MEN1）相关的大泌乳素瘤患者中，服用两片0.25毫克卡麦角林后发生张力性气颅。
BMJ Case Rep. 2013 Jun 7;2013:bcr2013009986. doi: 10.1136/bcr-2013-009986.
2
[Cabergoline-induced tension pneumocephalus in a patient with giant invasive prolactinoma. Case report].[卡麦角林诱发巨大侵袭性泌乳素瘤患者张力性气颅。病例报告]
Neurocirugia (Astur). 2011 Dec;22(6):558-61; discussion 561. doi: 10.1016/s1130-1473(11)70110-5.
3
Cabergoline-induced pneumocephalus in a medically treated macroprolactinoma.药物治疗的大泌乳素瘤中卡麦角林诱发的气颅
J Clin Endocrinol Metab. 2012 Oct;97(10):3412-3. doi: 10.1210/jc.2012-2245. Epub 2012 Jul 16.
4
Pneumocephalus during cabergoline treatment of an invasive macroprolactinoma.卡麦角林治疗侵袭性大泌乳素瘤期间出现气颅。
Acta Clin Belg. 2009 Sep-Oct;64(5):457. doi: 10.1179/acb.2009.078.
5
[Efficacy of cabergoline in the treatment of macroprolactinoma].卡麦角林治疗大泌乳素瘤的疗效
Presse Med. 2003 Jan 18;32(2):71-2.
6
Tumour shrinkage and chiasmal herniation after successful cabergoline treatment for a macroprolactinoma.卡麦角林成功治疗大泌乳素瘤后的肿瘤缩小及视交叉疝形成
Clin Endocrinol (Oxf). 2001 Jan;54(1):126-7. doi: 10.1046/j.1365-2265.2001.01150-2.x.
7
Acquired resistance to cabergoline: progression from initially responsive micro to macroprolactinoma.对卡麦角林产生获得性耐药：从最初有反应的微泌乳素瘤进展为大泌乳素瘤。
Pituitary. 2010 Dec;13(4):380-2. doi: 10.1007/s11102-010-0237-4.
8
Efficacy and safety of cabergoline as first line treatment for invasive giant prolactinoma.卡麦角林作为一线治疗药物治疗侵袭性巨大泌乳素瘤的疗效和安全性。
J Korean Med Sci. 2009 Oct;24(5):874-8. doi: 10.3346/jkms.2009.24.5.874. Epub 2009 Sep 24.
9
Secondary deterioration of visual field during cabergoline treatment for macroprolactinoma.卡麦角林治疗大泌乳素瘤期间视野的继发性恶化
Clin Endocrinol (Oxf). 2009 Apr;70(4):588-92. doi: 10.1111/j.1365-2265.2008.03364.x. Epub 2008 Jul 31.
10
SUNCT syndrome in a patient with prolactinoma and cabergoline-induced attacks.一名患有泌乳素瘤且出现卡麦角林诱发发作的患者的 SUNCT 综合征。
Cephalalgia. 2007 Jan;27(1):76-8. doi: 10.1111/j.1468-2982.2007.01229.x.
本文引用的文献
1
Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline.高泌乳素血症的诊断和治疗：内分泌学会临床实践指南。
J Clin Endocrinol Metab. 2011 Feb;96(2):273-88. doi: 10.1210/jc.2010-1692.
2
Nonsurgical cerebrospinal fluid rhinorrhea in invasive macroprolactinoma: incidence, radiological, and clinicopathological features.侵袭性大泌乳素瘤的非手术性脑脊液鼻漏：发病率、影像学及临床病理特征
J Clin Endocrinol Metab. 2007 Oct;92(10):3829-35. doi: 10.1210/jc.2007-0373. Epub 2007 Jul 10.
3
CSF rhinorrhoea following treatment with dopamine agonists for massive invasive prolactinomas.使用多巴胺激动剂治疗巨大侵袭性泌乳素瘤后出现脑脊液鼻漏。
Clin Endocrinol (Oxf). 2000 Jan;52(1):43-9. doi: 10.1046/j.1365-2265.2000.00901.x.
Zotero 插件